feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

InDex Pharmaceuticals: Full fart mot fas III

Research Note

2020-02-20

13:31

Vi ger en kort kommentar till dagens rapport från InDex Pharmaceuticals och den fördjupade analysen av CONDUCT-studien.

JS

Jakob Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.